Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:4285938.
doi: 10.1155/2016/4285938. Epub 2016 Oct 18.

Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases

Chang Youn Lee  1 , Ran Kim  2 , Onju Ham  3 , Jihyun Lee  2 , Pilseog Kim  2 , Seokyeon Lee  2 , Sekyung Oh  4 , Hojin Lee  5 , Minyoung Lee  6 , Jongmin Kim  7 , Woochul Chang  2
Affiliations
Review

Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases

Chang Youn Lee et al. Stem Cells Int. 2016.

Abstract

Despite development of medicine, cardiovascular diseases (CVDs) are still the leading cause of mortality and morbidity worldwide. Over the past 10 years, various stem cells have been utilized in therapeutic strategies for the treatment of CVDs. CVDs are characterized by a broad range of pathological reactions including inflammation, necrosis, hyperplasia, and hypertrophy. However, the causes of CVDs are still unclear. While there is a limit to the currently available target-dependent treatments, the therapeutic potential of stem cells is very attractive for the treatment of CVDs because of their paracrine effects, anti-inflammatory activity, and immunomodulatory capacity. Various studies have recently reported increased therapeutic potential of transplantation of microRNA- (miRNA-) overexpressing stem cells or small-molecule-treated cells. In addition to treatment with drugs or overexpressed miRNA in stem cells, stem cell-derived extracellular vesicles also have therapeutic potential because they can deliver the stem cell-specific RNA and protein into the host cell, thereby improving cell viability. Here, we reported the state of stem cell-based therapy for the treatment of CVDs and the potential for cell-free based therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Strategies for differentiation from somatic cells into cardiac lineage cells.
Figure 2
Figure 2
Two ways for inducing pluripotent cells from somatic cells.
See this image and copyright information in PMC

References

    1. Chao T. H., Chen I. C., Tseng S. Y., Li Y. H. Pluripotent stem cell therapy in ischemic cardiovascular disease. Zhonghua Minguo Xin Zang Xue Hui Za Zhi. 2014;30(5):365–374. - PMC - PubMed
    1. Elliott P., Andersson B., Arbustini E., et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2008;29(2):270–276. doi: 10.1093/eurheartj/ehm342. - DOI - PubMed
    1. Chen I. Y., Matsa E., Wu J. C. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nature Reviews Cardiology. 2016;13(6):333–349. doi: 10.1038/nrcardio.2016.36. - DOI - PMC - PubMed
    1. Gnecchi M., Zhang Z., Ni A., Dzau V. J. Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research. 2008;103(11):1204–1219. doi: 10.1161/circresaha.108.176826. - DOI - PMC - PubMed
    1. Tang Y. L., Zhao Q., Qin X., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. The Annals of Thoracic Surgery. 2005;80(1):229–237. doi: 10.1016/j.athoracsur.2005.02.072. - DOI - PubMed